210 related articles for article (PubMed ID: 15229648)
1. The Fos-related antigen Fra-1 is an activator of bone matrix formation.
Eferl R; Hoebertz A; Schilling AF; Rath M; Karreth F; Kenner L; Amling M; Wagner EF
EMBO J; 2004 Jul; 23(14):2789-99. PubMed ID: 15229648
[TBL] [Abstract][Full Text] [Related]
2. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1.
Jochum W; David JP; Elliott C; Wutz A; Plenk H; Matsuo K; Wagner EF
Nat Med; 2000 Sep; 6(9):980-4. PubMed ID: 10973316
[TBL] [Abstract][Full Text] [Related]
3. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
4. Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1.
Roschger P; Matsuo K; Misof BM; Tesch W; Jochum W; Wagner EF; Fratzl P; Klaushofer K
Bone; 2004 May; 34(5):776-82. PubMed ID: 15121008
[TBL] [Abstract][Full Text] [Related]
5. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
6. Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1.
Julien M; Khoshniat S; Lacreusette A; Gatius M; Bozec A; Wagner EF; Wittrant Y; Masson M; Weiss P; Beck L; Magne D; Guicheux J
J Bone Miner Res; 2009 Nov; 24(11):1856-68. PubMed ID: 19419315
[TBL] [Abstract][Full Text] [Related]
7. Elevated Fra-1 expression causes severe lipodystrophy.
Luther J; Driessler F; Megges M; Hess A; Herbort B; Mandic V; Zaiss MM; Reichardt A; Zech C; Tuckermann JP; Calkhoven CF; Wagner EF; Schett G; David JP
J Cell Sci; 2011 May; 124(Pt 9):1465-76. PubMed ID: 21486951
[TBL] [Abstract][Full Text] [Related]
8. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production.
Bozec A; Bakiri L; Jimenez M; Schinke T; Amling M; Wagner EF
J Cell Biol; 2010 Sep; 190(6):1093-106. PubMed ID: 20837772
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1.
Nishiwaki T; Yamaguchi T; Zhao C; Amano H; Hankenson KD; Bornstein P; Toyama Y; Matsuo K
J Bone Miner Res; 2006 Apr; 21(4):596-604. PubMed ID: 16598380
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.
Carrasco D; Bravo R
Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631
[TBL] [Abstract][Full Text] [Related]
11. Osteoblasts develop from isolated fetal mouse chondrocytes when co-cultured in high density with brain tissue.
Groot CG; Thesingh CW; Wassenaar AM; Scherft JP
In Vitro Cell Dev Biol Anim; 1994 Aug; 30A(8):547-54. PubMed ID: 7702653
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone.
Salie R; Kneissel M; Vukevic M; Zamurovic N; Kramer I; Evans G; Gerwin N; Mueller M; Kinzel B; Susa M
Bone; 2010 Mar; 46(3):680-94. PubMed ID: 19857617
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
[TBL] [Abstract][Full Text] [Related]
14. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
16. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.
Schinke T; Liese S; Priemel M; Haberland M; Schilling AF; Catala-Lehnen P; Blicharski D; Rueger JM; Gagel RF; Emeson RB; Amling M
J Bone Miner Res; 2004 Dec; 19(12):2049-56. PubMed ID: 15537449
[TBL] [Abstract][Full Text] [Related]
17. Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage.
Ushiku C; Adams DJ; Jiang X; Wang L; Rowe DW
J Orthop Res; 2010 Oct; 28(10):1338-47. PubMed ID: 20839319
[TBL] [Abstract][Full Text] [Related]
18. Fos- and Jun-related transcription factors are involved in the signal transduction pathway of mechanical loading in condylar chondrocytes.
Papachristou D; Pirttiniemi P; Kantomaa T; Agnantis N; Basdra EK
Eur J Orthod; 2006 Feb; 28(1):20-6. PubMed ID: 16373449
[TBL] [Abstract][Full Text] [Related]
19. Collagen XXIV (Col24a1) gene expression is a specific marker of osteoblast differentiation and bone formation.
Matsuo N; Tanaka S; Yoshioka H; Koch M; Gordon MK; Ramirez F
Connect Tissue Res; 2008; 49(2):68-75. PubMed ID: 18382892
[TBL] [Abstract][Full Text] [Related]
20. Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions.
Kashima TG; Nishiyama T; Shimazu K; Shimazaki M; Kii I; Grigoriadis AE; Fukayama M; Kudo A
Hum Pathol; 2009 Feb; 40(2):226-37. PubMed ID: 18799196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
